Strata Critical Medical (SRTA) Long-Term Investments (2019 - 2023)

Strata Critical Medical has disclosed Long-Term Investments across 5 years of filings, most recently posting $390000.0 for Q3 2023.

• In Q3 2023, Long-Term Investments changed 0.0% year-over-year to $390000.0; the TTM figure through Sep 2023 stood at $390000.0 (changed 0.0% YoY), while the FY2022 annual figure was $390000.0, up 95.0% from the prior year.
• Long-Term Investments steadied at $390000.0 in Q3 2023, from $390000.0 in the prior quarter.
• Over the last five years, Long-Term Investments for SRTA reached as high as $277.2 million in Q2 2020 and fell as low as $200000.0 in Q3 2020.
• The 5-year median for Long-Term Investments is $390000.0 (2022), against an average of $97.8 million.
• Annual changes were most pronounced in 2021 — Long-Term Investments tumbled 99.93% — and 2022, when it soared 95.0%.
• A 5-year view of Long-Term Investments shows it stood at $276.3 million in 2019, then climbed by 0.25% to $276.9 million in 2020, then tumbled by 99.93% to $200000.0 in 2021, then soared by 95.0% to $390000.0 in 2022, then changed by 0.0% to $390000.0 in 2023.
• According to Business Quant data, Long-Term Investments over the past three periods registered $390000.0, $390000.0, and $390000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.